SBFM Sunshine Biopharma Inc.
$3.11▲ +5.07%
Healthcare
Other
After hours
$3.10▼ -0.32%
Oct 28, 7:59 PM ET
Volume 221.9K
Avg Volume (10D) 124.8K
Key Metrics & Fundamentals
Market Cap
$2.37M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.58 - 464.00
% vs 50 MA
200.63%
% vs 200 MA
-44.91%
RSI-14
74.9
MACD Histogram
+0.3400
Beta (1Y vs SPY)
-10.40
Free Cash Flow
-$923,097
Gross Rev
$9.26M
Gross Profit
$2.43M
EBITDA
-$1.53M
COGS
$6.84M
Operating Exp
$4.04M
Operating Income
-$1.61M
EBIT
-$1.61M
Pretax Income
-$1.56M
Net Income
-$1.56M
EPS (Diluted)
-1.15
Price & Volume History
Loading chart…
Recent News
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
ACCESS Newswire · Oct 22, 2026 9:00 AM ET
Sunshine Biopharma Closes $6 Million Equity Offering
MT Newswires · Oct 12, 2026 6:22 AM ET
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
ACCESS Newswire · Oct 9, 2026 11:17 AM ET
Sunshine Biopharma Prices $6 Million Public Offering at $0.55 Per Unit, Raising Dilution Concerns
InvestorsHub · Oct 8, 2026 10:40 AM ET
BC-Most Active Stocks
Associated Press · Oct 8, 2026 10:30 AM ET
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
ACCESS Newswire · Oct 8, 2026 8:00 AM ET
BC-Most Active Stocks
Associated Press · Oct 7, 2026 10:30 AM ET
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know
Zacks · Sep 24, 2026 11:00 AM ET
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
ACCESS Newswire · Sep 24, 2026 9:00 AM ET
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
ACCESS Newswire · Sep 16, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SBFM's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.